GILD Stock Performance, Insider Transaction and News

GILD - Gilead Sciences, Inc.

Market Cap	94.40B	P/E	17.12	EPS this Y	-40.30%	Ern Qtrly Grth	-
Income	485M	Forward P/E	11.63	EPS next Y	90.90%	50D Avg Chg	-2.00%
Sales	27.45B	PEG	3.15	EPS past 5Y	1.66%	200D Avg Chg	-6.00%
Dividend	4.00%	Price/Book	4.50	EPS next 5Y	5.38%	52W High Chg	-16.00%
Recommedations	2.50	Quick Ratio	0.78	Shares Outstanding	1.25B	52W Low Chg	25.00%
Insider Own	0.11%	ROA	10.50%	Shares Float	1.24B	Beta	0.22
Inst Own	88.01%	ROE	2.39%	Shares Shorted/Prior	21.70M/21.18M	Price	75.68
Gross Margin	77.52%	Profit Margin	1.77%	Avg. Volume	5,671,716	Target Price	81.21
Oper. Margin	34.43%	Earnings Date	Aug 8	Volume	5,249,684	Change	0.00%

Healthcare | Drug Manufacturers - General | United States

About Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Gilead Sciences, Inc. News

06/14/24	Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
06/14/24	Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.
06/14/24	Gilead Sciences Inc's Dividend Analysis
06/14/24	New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment
06/13/24	Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
06/12/24	How Luciana Preger Is Helping Advance Gilead’s Work in Oncology
06/08/24	3 Stocks With Mouthwatering Dividends You Can Buy Right Now
06/07/24	Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
06/06/24	Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
06/06/24	Gilead Says Bulevirtide With PegIFN Data 'Superior' to Bulevirtide Monotherapy; Achieves 46% Rate of Undetectable HDV RNA
06/06/24	Gilead’s seladelpar shows promise in primary biliary cholangitis trial
06/06/24	Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA
06/05/24	Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
06/05/24	Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis
06/05/24	Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
06/05/24	The Dividend Dynamos: 7 Stocks That Will Energize Your Income Stream
06/05/24	7 Dividend Stocks to Invest In for a Lifetime of Income
06/05/24	Gilead progresses subject enrolment in HIV prevention trials
06/05/24	J&J seeks expanded approvals for paediatric HIV-1 therapy
06/05/24	Gilead’s Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis

GILD Chatroom

ElijahJobs Posted - 1 hour ago

$GILD Friday saw 8.7M shares in the regular session and another 1.1M shares in AH session. Big, huge rally coming this week!! JMO

CodySalkauskas Posted - 2 hours ago

$gild $bmy Analyst price target for next week. stock-thoughts-winning.surprise-again.xyz

2030orbust Posted - 4 hours ago

$GILD oral GLP-1 pill could send this to prior highs 😳 https://t.co/3Gr7dWPnHD

2030orbust Posted - 4 hours ago

$GILD a wild chart which shows we are reclaiming the all time trend line based on Fridays close (hard to see given the chart spans a decade +). Great volume on Friday on an ex div date. Look for this to reclaim the $70s by end of July IMO

QuiverQuant Posted - 1 day ago

CONGRESSIONAL TRADING: Senator Tuberville, Tommy disclosed a sale (full) of $1,001 - $15,000 of $GILD on 2024-06-14.

nycmax Posted - 1 day ago

$ALT $Gild announces results from oral glp drug they are developing at ADA 2024 and partnered with another small biotech for new obesity compounds (small sub 50m deal) . Cross out another bp partner out. Superpumpers keep deflecting from the marketplace going all in on oral drugs because no one wants to invest 5b to manufacture jabs and peptides to take on lly and nvo. Garg knows this and should take any deal now.

StockInvest_us Posted - 1 day ago

Signal alert: $GILD - Possible Runner https://stockinvest.us/l/DHCF1iztcQ

Investfaithfully Posted - 1 day ago

$ATNM $GILD how much for the buyout? do you think 7 billion at least?

resume777 Posted - 1 day ago

@Ferric CAR-T news for $gild today https://www.gilead.com/news-and-press/press-room/press-releases/2024/6/new-kite-clinical-research-and-real-world-evidence-for-yescarta-demonstrate-benefit-from-earlier-lines-of-treatment

Ferric Posted - 1 day ago

$ATNM why is $GILD trending on market watch? And are they negotiating with Sandy? Another day to closure people

ElijahJobs Posted - 1 day ago

$GILD Never liked dividends. Gives but takes out of the stock price. Only matters for tax purposes. Besides, most institutional investors automatically re-invest divis. Nothing burger to me. Next week, we will test recovering 70. JMO

malky2945 Posted - 1 day ago

$GILD like green on undervalued gems, but the reason today is just hype, not fundamental.

sagittarian Posted - 2 days ago

$GILD just happened to be in ex div day 0.77 c -- causing shorts to cover

ElijahJobs Posted - 2 days ago

$GILD Surprise Weight Loss Drug of its own. Isn't that nice? LOL https://finance.yahoo.com/m/67de46c0-3f75-3fc8-8899-ef3ae85642e2/gilead-sciences-jumps-after.html?

DesiHFM Posted - 2 days ago

$GILD either add AI or say working on obesity to push your stock up these days 😆😆😆

2030orbust Posted - 2 days ago

$GILD with a big move on an ex div date and a red market 😳

Dragon_Trader2024 Posted - 2 days ago

$VKTX will $GILD buy them out? https://www.barrons.com/articles/gilead-stock-price-obesity-drugs-glp1-a3c13eb3

SilverTrader47 Posted - 2 days ago

@OpenHandClosedFist I have been waiting to buy $GILD at $62 or less a share. I started a $VSAT position at $13.25 - $13.40, and I have been adding undervalued $MOS.

wilno Posted - 2 days ago

$GILD 75 by eoy! Fearless!

bachor Posted - 2 days ago

$GILD I saw Gilead rising. That was such a great feeling for 15 minutes. I really hope it gets back up.

MichaelSchumacher Posted - 2 days ago

$GILD I am interested

JGNYC Posted - 2 days ago

$VKTX $GILD dropping GLP1 oral molecule data shessh

ElijahJobs Posted - 2 days ago

$GILD YEEHAW!

ElijahJobs Posted - 2 days ago

$GILD How cheap is GILD now? Based on the 2025 EPS estimates, the current forward PE is 9. The current P/S is only 2.9, which is much lower than other BP's. It has $5.5B cash and $25B debt but its positive cashflow is $8.4B. The pipeline is very robust, too. The fair value minimum is $85. JMO

joedoe18 Posted - 2 days ago

$GILD started a position here … too cheap to ignore 🫦

vsfan Posted - 2 days ago

$GILD low volume, near ATL, is it a buy signal ?

ElijahJobs Posted - 2 days ago

$GILD Just as I expected. Time to bulldozer some bears really badly. LMAO

vsfan Posted - 2 days ago

$GILD almost 52 wk low, what is so wrong about this company?

Motherloads Posted - 2 days ago

$GILD ✅👌💰

resume777 Posted - 2 days ago

$ATNM The amount of PR released over the last month. This is more PR than we've seen historically in the previous 5 years in a small period; 10 PR announcements in just the last week. All roads lead to better CAR-T conditioning, novel radiotherapy treatment for r/r AML, and an Actinium-225 radioisotope manufacturing solution. May the highest bidder win! $BMY $NVS $JNJ $GILD https://stocktwits.com/resume777/message/576559046

Analyst Ratings

RBC Capital	Sector Perform	Jun 14, 24
Barclays	Equal-Weight	Apr 29, 24
TD Cowen	Buy	Apr 26, 24
Morgan Stanley	Equal-Weight	Apr 26, 24
RBC Capital	Sector Perform	Apr 26, 24
Needham	Hold	Apr 26, 24
HSBC	Hold	Apr 24, 24
Oppenheimer	Outperform	Apr 19, 24
UBS	Neutral	Apr 17, 24

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Dickinson Andrew D	Chief Financial Offi.. Chief Financial Officer	Jan 16	Sell	85.78	5,000	428,900	101,534	01/17/24
Mercier Johanna	Chief Commercial Off.. Chief Commercial Officer	Jan 09	Sell	85.23	8,242	702,466	82,729	01/10/24
Parsey Merdad	Chief Medical Office.. Chief Medical Officer	Sep 12	Sell	76.99	1,501	115,562	70,130	09/13/23
Dickinson Andrew D	Chief Financial Offi.. Chief Financial Officer	Jul 20	Sell	80.00	5,000	400,000	107,587	07/21/23
Parsey Merdad	Chief Medical Office.. Chief Medical Officer	Jun 13	Sell	76.90	1,485	114,197	29,402	06/14/23
Parsey Merdad	Chief Medical Office.. Chief Medical Officer	Mar 13	Sell	78.99	6,126	483,893	70,130	03/14/23
Lofton Kevin E	Director Director	Mar 09	Option	52.38	8,442	442,192	8,442	03/10/23
Parsey Merdad	Chief Medical Office.. Chief Medical Officer	Mar 01	Sell	79.9619	12,984	1,038,225	70,130	03/02/23
Parsey Merdad	Chief Medical Office.. Chief Medical Officer	Dec 30	Sell	85.33	553	47,187	45,556	01/03/23
Wilfong Diane E.	SVP, Controller & CA.. SVP, Controller & CAO	Nov 01	Option	72.7	16,255	1,181,738	44,588	11/02/22
Wilfong Diane E.	SVP, Controller & CA.. SVP, Controller & CAO	Nov 01	Sell	79.25	16,255	1,288,209	28,333	11/02/22
Lofton Kevin E	Director Director	Apr 28	Option	25.625	16,322	418,251	90,525	04/29/22
Pletcher Brett A	EVP,Corp Affairs & G.. EVP,Corp Affairs & Gen Counsel	Mar 10	Sell	58.24	3,634	211,644	32,576	03/14/22
Pletcher Brett A	EVP,Corp Affairs & G.. EVP,Corp Affairs & Gen Counsel	Feb 09	Sell	63.89	1,691	108,038	32,576	02/11/22
Pletcher Brett A	EVP,Corp Affairs & G.. EVP,Corp Affairs & Gen Counsel	Feb 01	Sell	68.5358	14,061	963,682	32,576	02/02/22
Wilfong Diane E.	SVP, Controller & CA.. SVP, Controller & CAO	Aug 18	Sell	72.5	13,610	986,725	20,398	08/18/21
Wilfong Diane E.	SVP, Controller & CA.. SVP, Controller & CAO	Aug 18	Option	67.56	13,610	919,492	34,008	08/18/21
Whitley Richard James	Director Director	May 04	Option	20.65	20,282	418,823	51,404	05/04/21